BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 17470129)

  • 1. Helicobacter pylori infection-negative gastric cancer in Japanese hospital patients: incidence and pathological characteristics.
    Kato S; Matsukura N; Tsukada K; Matsuda N; Mizoshita T; Tsukamoto T; Tatematsu M; Sugisaki Y; Naito Z; Tajiri T
    Cancer Sci; 2007 Jun; 98(6):790-4. PubMed ID: 17470129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fasting gastric pH of Japanese subjects stratified by IgG concentration against Helicobacter pylori and pepsinogen status.
    Kishikawa H; Nishida J; Ichikawa H; Kaida S; Takarabe S; Matsukubo T; Miura S; Morishita T; Hibi T
    Helicobacter; 2011 Dec; 16(6):427-33. PubMed ID: 22059393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combining the serum pepsinogen level and Helicobacter pylori antibody test for predicting the histology of gastric neoplasm.
    Choi HS; Lee SY; Kim JH; Sung IK; Park HS; Shim CS; Jin CJ
    J Dig Dis; 2014 Jun; 15(6):293-8. PubMed ID: 24602176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of gastric cancer in asymptomatic, middle-aged Japanese subjects based on serum pepsinogen and Helicobacter pylori antibody levels.
    Yanaoka K; Oka M; Yoshimura N; Mukoubayashi C; Enomoto S; Iguchi M; Magari H; Utsunomiya H; Tamai H; Arii K; Yamamichi N; Fujishiro M; Takeshita T; Mohara O; Ichinose M
    Int J Cancer; 2008 Aug; 123(4):917-26. PubMed ID: 18508314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Helicobacter pylori infection combined with CagA and pepsinogen status on gastric cancer development among Japanese men and women: a nested case-control study.
    Sasazuki S; Inoue M; Iwasaki M; Otani T; Yamamoto S; Ikeda S; Hanaoka T; Tsugane S;
    Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1341-7. PubMed ID: 16835334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastric mucosa in Mongolian and Japanese patients with gastric cancer and Helicobacter pylori infection.
    Matsuhisa T; Yamaoka Y; Uchida T; Duger D; Adiyasuren B; Khasag O; Tegshee T; Tsogt-Ochir B
    World J Gastroenterol; 2015 Jul; 21(27):8408-17. PubMed ID: 26217093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serological assessment of gastric mucosal atrophy in gastric cancer.
    Bornschein J; Selgrad M; Wex T; Kuester D; Malfertheiner P
    BMC Gastroenterol; 2012 Jan; 12():10. PubMed ID: 22289789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency of Helicobacter pylori -negative gastric cancer and gastric mucosal atrophy in a Japanese endoscopic submucosal dissection series including histological, endoscopic and serological atrophy.
    Ono S; Kato M; Suzuki M; Ishigaki S; Takahashi M; Haneda M; Mabe K; Shimizu Y
    Digestion; 2012; 86(1):59-65. PubMed ID: 22722747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum pepsinogen values and Helicobacter pylori status among control subjects of a nested case-control study in the JACC study.
    Kikuchi S; Yagyu K; Obata Y; Yingsong L; Yatsuya H; Hoshiyama Y; Kondo T; Sakata K; Mizoue T; Tokui N; Fujino Y; Tamakoshi A; Toyoshima H; Ishibashi T; Hayakawa N; Yoshimura T;
    J Epidemiol; 2005 Jun; 15 Suppl 2(Suppl II):S126-33. PubMed ID: 16127224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Re-expression of sonic hedgehog and reduction of CDX2 after Helicobacter pylori eradication prior to incomplete intestinal metaplasia.
    Shiotani A; Uedo N; Iishi H; Tatsuta M; Ishiguro S; Nakae Y; Kamada T; Haruma K; Merchant JL
    Int J Cancer; 2007 Sep; 121(6):1182-9. PubMed ID: 17520681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two distinct aetiologies of cardia cancer; evidence from premorbid serological markers of gastric atrophy and Helicobacter pylori status.
    Hansen S; Vollset SE; Derakhshan MH; Fyfe V; Melby KK; Aase S; Jellum E; McColl KE
    Gut; 2007 Jul; 56(7):918-25. PubMed ID: 17317788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A retrospective study assessing the acceleration effect of type I Helicobacter pylori infection on the progress of atrophic gastritis.
    Liu W; Tian J; Hui W; Kong W; Feng Y; Si J; Gao F
    Sci Rep; 2021 Feb; 11(1):4143. PubMed ID: 33603125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Helicobacter pylori infection and serum level of pepsinogen are associated with the risk of metachronous gastric neoplasm after endoscopic resection.
    Kwon Y; Jeon S; Nam S; Shin I
    Aliment Pharmacol Ther; 2017 Oct; 46(8):758-767. PubMed ID: 28799258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low prevalence of Helicobacter pylori-negative gastric cancer among Japanese.
    Matsuo T; Ito M; Takata S; Tanaka S; Yoshihara M; Chayama K
    Helicobacter; 2011 Dec; 16(6):415-9. PubMed ID: 22059391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Helicobacter pylori infection and markers of gastric cancer risk in Alaska Native persons: a retrospective case-control study.
    Keck JW; Miernyk KM; Bulkow LR; Kelly JJ; McMahon BJ; Sacco F; Hennessy TW; Bruce MG
    Can J Gastroenterol Hepatol; 2014 Jun; 28(6):305-10. PubMed ID: 24945184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer development based on chronic active gastritis and resulting gastric atrophy as assessed by serum levels of pepsinogen and Helicobacter pylori antibody titer.
    Yoshida T; Kato J; Inoue I; Yoshimura N; Deguchi H; Mukoubayashi C; Oka M; Watanabe M; Enomoto S; Niwa T; Maekita T; Iguchi M; Tamai H; Utsunomiya H; Yamamichi N; Fujishiro M; Iwane M; Takeshita T; Ushijima T; Ichinose M
    Int J Cancer; 2014 Mar; 134(6):1445-57. PubMed ID: 24009139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Barrett's esophagus is characterized by the absence of Helicobacter pylori infection and high levels of serum pepsinogen I concentration in Japan.
    Abe Y; Iijima K; Koike T; Asanuma K; Imatani A; Ohara S; Shimosegawa T
    J Gastroenterol Hepatol; 2009 Jan; 24(1):129-34. PubMed ID: 19196398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of gastric cancer in negative test of serum anti-Helicobacter pylori antibody and pepsinogen test: a multicenter study.
    Kiso M; Yoshihara M; Ito M; Inoue K; Kato K; Nakajima S; Mabe K; Kobayashi M; Uemura N; Yada T; Oka M; Kawai T; Boda T; Kotachi T; Masuda K; Tanaka S; Chayama K
    Gastric Cancer; 2017 Sep; 20(5):764-771. PubMed ID: 28025702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutoff Pepsinogen Level for Predicting Unintendedly Eradicated Cases of Helicobacter pylori Infection in Subjects with Seemingly Normal Pepsinogen Levels.
    Kishikawa H; Kimura K; Ito A; Arahata K; Takarabe S; Kaida S; Miyauchi J; Miura S; Kanai T; Nishida J
    Digestion; 2017; 95(3):229-236. PubMed ID: 28355604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The correlation between histological gastritis staging- 'OLGA/OLGIM' and serum pepsinogen test in assessment of gastric atrophy/intestinal metaplasia in China.
    Wang X; Lu B; Meng L; Fan Y; Zhang S; Li M
    Scand J Gastroenterol; 2017 Aug; 52(8):822-827. PubMed ID: 28436254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.